CSDX · Cs Diagnostics Corp.
Market Cap
$1.44M
Shares
137.34M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W close$0.01–0.40
Avg vol 30d120K
Short int1K · 0.0% float
Short vol2%
DataAug 2023–Aug 2026
Filing10-K · Apr 15
Raw chart and full-history price indicators begin at the captured split on Aug 3, 2023; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−94%
below
Price vs 50-day avg
−83%
below
RSI (14)
32
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−70%
trailing
6-month return
−95%
trailing
YTD return
−97%
this year
Relative strength
−106%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
11
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
299%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
261.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−94%
Bearish
Price vs 50-day avg
−83%
Bearish
RSI (14)
32
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $0
vs 200-day avg -94%
vs 50-day avg -83%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CSDX
this stock
Cs Diagnostics Corp.
|
$1.44M | -96.6% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$191.81B | -11.9% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -7.9% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$116.78B | -5.6% | +8.4% | 24.5 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.3% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Performance
Raw-price comparisons begin at the captured split on Aug 3, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CSDX | -85.0% | -69.6% | -95.0% | -85.0% | -96.6% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -83.0% | -72.9% | -106.2% | -87.1% | -108.4% |